Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-23
1993-01-05
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548429, C07D48704, A61K 3140
Patent
active
051771012
ABSTRACT:
There are disclosed various derivatives related to physostigmine of the formula below, ##STR1## where Z, R.sub.1 and R.sub.2 are as defined in the specification, which compounds are useful for enhancing cholinergic function, and as analgesic agents.
REFERENCES:
patent: 4680172 (1987-07-01), Leeson
patent: 4765985 (1988-08-01), Leeson
patent: 4791107 (1988-12-01), Hamer
patent: 4831155 (1989-05-01), Brufani
patent: 4900748 (1990-02-01), Brossi
Brossi, specification of SN166824.
Yu, Heterocycles 27, 745 (1988).
Yu, FEBS Letters 234, 127, 130 (1988).
Atack, J. Pharm. Exp. Ther. 249 194-202.
Fritz, Tetrahedron 26, 5821 (1970).
Chiang Yulin
Glamkowski Edward J.
Hamer Russell R. L.
Berch Mark L.
Hoechst-Roussel Pharmaceuticals Incorporated
Ikeda Tatsuya
LandOfFree
Memory enhancing and analgesic aminocarbonylcarbamates related t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Memory enhancing and analgesic aminocarbonylcarbamates related t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memory enhancing and analgesic aminocarbonylcarbamates related t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2390806